SCHEMBL6514641

SCHEMBL6514641

CC(C)CCn1c(=O)c(C(=O)O)c(O)c2c(Cl)cccc21

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.43
KMT2A Q03164 8/20 0.43
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
XBP1 P17861 1/20 0.41
NPC1 O15118 3/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
EGFR P00533 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CHEK1 O14757 1/20 0.38
WEE1 P30291 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1523071 0.85 KDM4E (0.52) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL15936261 0.85 MEN1 (0.51) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL889415 0.79 EGFR (0.51) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL1523407 0.75 MEN1 (0.58) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL28036699 0.72 KDM4E (0.66) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL30884503 0.71 MEN1 (0.50) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL1522411 0.71 ALDH1A1 (0.40) KMT2AALDH1A1KDM4EHTTSMN1; SMN2
SCHEMBL16099904 0.71 EGLN1 (0.47) MEN1KMT2AKDM4E
SCHEMBL28676384 0.70 KDM4E (0.51) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL6732535 0.70 HSD17B10 (0.38) MEN1KMT2AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT MEN1 4797/4885KMT2A 4532/4885ALDH1A1 1592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.